Please login to the form below

Not currently logged in
Email:
Password:

Envigo appoints Patricia Henahan as chief financial officer

She brings experience from AZ, Eli Lilly and Hospira

Envigo Patricia HenahanResearch company Envigo - formerly known as Huntindon Life Sciences - has appointed Patricia Henahan as its new chief financial officer.

Henahan brings 15 years of financial experience in the life science sector, including senior leadership roles at AstraZeneca, Eli Lilly and MedImmune.

Most recently, she served as vice president of finance for Hospira's US commercial operations.

Brian Cass, chief executive officer at Envigo, said: “I am delighted that Pat has decided to join the team at Envigo.

“Her background in pharmaceuticals and experience across the research and development process will bring valuable insight to our strategic planning as we continue to position Envigo as a leading provider of contract services and research models globally.”

21st June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
The concordance conundrum: creating space for open dialogue
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...
Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...

Infographics